11
May

08:00 AM PDT

Clinical Operations
Strategy Meeting West Coast USA 2023

Name: Clinical Operations Conferences 2023
Start: 2023-05-11T08:00
End: 2023-05-11T16:50
Location: Hard Rock Hotel San Diego

Jumpstart Clinical Operations on Patient Centricity, Innovation and Efficiency

Hard Rock Hotel San Diego

A MEETING EXPERIENCE UNLIKE ANY OTHER

Fresh Clinical Operations Insights

Tired of the same conference experience? Real discussions and genuine networking are often promised, but not always delivered.

Proventa International’s Clinical Strategy Meetings are designed to avoid the pitfalls of a typical conference, by providing the right environment to make those important connections through interactive roundtable discussions, exclusive networking and keynote panel debates. Join Clinical Operations professionals from across the West Coast in San Diego, to discover new insights and take your company’s mission to the next level.

What makes our strategy meetings unique?

Roundtable Discussions

Intimate discussions led by renowned industry experts. Have your voice heard and debate alongside like-minded life science executives.

Unrivalled Networking

With senior delegation from big pharma and innovative biotech from across the West Coast, you can network with peers from different locations, all in one place.

Personalised Agenda

Choose the topics that matter to you. Reserve your place at the roundtable discussions and ensure your whole day delivers the insights you need to hear.

Solutions to your Problems

We’ve partnered with the best solution providers to solve your biggest challenges. Engage in pre-arranged, private meetings to address your specific needs and find a tangible solution.

Industry Researched Topics

We guarantee our agenda is up-to-date and mission critical because its designed by you. We speak to our extended network of senior decision makers to ensure the most important topics are discussed.

Senior Decision Makers

The entire strategy meeting is specifically tailored to the needs and challenges of senior life science professionals. Discover how your peers are dealing with the same challenges as you.

Meet Our Facilitators

Our panel of facilitators play a key role in shaping the agenda for the day. See who will be bringing their expertise to the table at Clinical Operations Strategy Meetings.

Adrian Kizewski

Associate Director RBQM Technology IQVIA

Ana Krtolica

Senior Vice President, Preclinical Development Oryn Therapeutics

Alejandra Maciel

Vice President, Clinical Affairs Epigenomics

Angela Pietrofeso

Vice President, Clinical Development Operations Oncternal Therapeutics

Arun Sivanandam

Associate Director, Global Clinical Development and Operations Santen Pharmaceuticals

Ben Cadieux

Vice President of Medical Affairs MEI Pharma

Bonne Adams

Chief Operating Officer Tracon Tracon Pharmaceuticals

Ms. Adams joined us as our Vice President of Clinical Operations in August 2006, was promoted to Senior Vice President of Clinical Operations in July 2014, and was promoted to Executive Vice President of Clinical Operations in January 2019. Prior to joining us, Ms. Adams was a Manager of Clinical Operations at Pfizer, Inc., a pharmaceutical corporation, from 2004 to 2006 and at Biogen Idec, Inc., a biotechnology company, from 2002 to 2004. Ms. Adams managed clinical trials at Pfizer that contributed to the 2006 approval of Sutent® in renal cell carcinoma and gastrointestinal stromal tumors, and she managed clinical trials at Biogen Idec that fulfilled post-approval commitments for Zevalin® and Rituxan®. Ms. Adams has managed both early and late-stage oncology studies of small molecules as well as biologics in the areas of lymphoma, lung, colorectal, ovarian, kidney, sarcoma and breast cancers. From 2000 to 2002, she managed non-oncology programs at Quintiles Inc., a service provider for biopharmaceutical and health sciences companies, including studies in the areas of allergy and pulmonary disease. Ms. Adams received a B.A. in Kinesiology and Biology from the University of Colorado and an M.B.A. in Technology Management from The University of Phoenix.

Chad Moore

Co-Founder & Corporate Development Elligo Health Research

Christopher Mizer

President and CEO Vivaris Capital

Daniel Gebremedhin

Partner Flare Capital Partners

Dan Gebremedhin, MD is a Partner at Flare Capital Partners and serves on the Board of Flare portfolio companies Somatus, Eden Health, Positive Development, Vita Health, Oui Health, and Elektra Health. Prior to joining Flare Capital, Dan served as a Medical Director at the Harvard Pilgrim Health Plan. Dan spent over 8 years as a practicing Internal Medicine Physician on the Faculty of the Massachusetts General Hospital and Instructor in Medicine at Harvard Medical School, after completing Internal Medicine Residency at the Massachusetts General Hospital in 2010. Dan served on Former Massachusetts Governor Charlie Baker’s Board of Nursing Home Administrators from 2016 to 2020. He has served as a Senior Health Policy Advisor for the Campaigns of Former Governor Charlie Baker, Former Congressman Joseph Kennedy III and Congressman Jake Auchincloss. Dan earned a BS from the University of California, San Diego, an MD from the Morehouse School of Medicine, and an MBA from the Harvard Business School

Faith Holmes, M.D.

Medical Director, Senior Vice President of Medical Affairs Elligo Health Research

Faith Holmes, M.D., brings more than 30 years of experience in direct patient care, and 11 years of medical practice management to her role as Elligo’s Senior Vice President of Medical Affairs. Her unique perspective plays an important part in building the company’s network of Research Ready physician practices and preparing them to conduct research. Holmes’ rich perspective — including experience in family medicine, hospice, and palliative medicine that spans solo practice and single specialty and multispecialty group practices — allows her to build rapport with study managers, site staff, and investigators, and provide medical and scientific knowledge to support future growth. Holmes has served as the Principal Investigator for interventional, diagnostic device, and observational trials in several therapeutic indications in Elligo’s eSolutions model and at the Elligo Clinical Research Center. She earned her Bachelor of Science degree in chemistry and biology from Trevecca University, her Doctor of Medicine degree from ORU School of Medicine, and is board certified in family medicine and hospice and palliative medicine.

George Ng

Board Director, President & COO Calidi Biotherapeutics

Jack Florio

Managing Director Weild & Co

Jayasri Vaidyanath

Associate Director, Product Management IQVIA Technologies

Matt Sharma

Senior Clinical Trials Manager Arcturus Therapeutics

Melody Anderson

Executive Director, Clinical Operations Avelas Biosciences

Moya Daniels

SVP, Regulatory Affairs, Clinical Operations and Quality Indapta Therapeutics

Patrick Harrington, Ph.D.

Vice President of Elligo Solutions Elligo Health Research

Dr. Patrick Harrington has over 25 years of scientific research and clinical experience in a broad variety of neuropsychiatric disorders. He has presented his research at professional meetings both nationally and internationally, and co-authored several publications in peer reviewed journals. Patrick has worked on numerous psychiatry trials with sponsors all around the globe. He was the leader for a Clinical Surveillance and Training team where he helped develop pre-enrollment review and a statistical analysis program to assess ongoing patient ratings. He has also created several scales used in clinical trials, collaborated with PIs on randomization decisions within the trial, and helped identify diagnostic and rating problems. In his role with Elligo, Patrick is helping to revolutionize the way clinical trials are designed and run. He holds a doctorate in clinical psychology, with a focus in clinical neuropsychology, from University of Texas at Austin. He won the American Neuropsychiatric Association Young Investigator Award in 1997. For more information, visit <a href="https://www.elligohealthresearch.com/">ElligoHealthResearch.com</a>.

Sagar Vaidya

Vice President of Clinical Development Travere Therapeutics

Sandra Wiley

Director, Translational Sciences MEI Pharma

Wendy Morahan

Senior Director, Clinical Data Analytics Clinical Data Analytics IQVIA

See the agenda and facilitator line-up Download the strategy meeting brochure for full details

DOWNLOAD THE BROCHURE

Reasons To Attend Our Strategy Meetings

Fully Interactive Format

There’s only so much you can learn from presentations and lectures. Instead our interactive Roundtable Discussions let you debate the topics that really matter

Senior Decision Makers

All our Strategy Meetings are aimed at director level and above. Discover how your peers are tackling the industries biggest challenges and have your thoughts heard

Personalised Agendas

Pick the roundtable discussions that you want to be part of. Simply choose your sessions and we’ll create a personalised agenda just for you

Private and Intimate Networking

Small group discussions, private meetings, networking drinks – however you choose to make those important connections our Strategy Meetings have the solution